Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$25.96 - $33.44 $285,560 - $367,840
-11,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$27.56 - $40.37 $26,953 - $39,481
-978 Reduced 8.16%
11,000 $363,000
Q4 2020

Feb 02, 2021

SELL
$31.74 - $51.34 $6,348 - $10,268
-200 Reduced 1.64%
11,978 $433,000
Q3 2020

Nov 05, 2020

BUY
$30.96 - $44.39 $377,030 - $540,581
12,178 New
12,178 $413,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.